Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Takeda Pharmaceutical (TAK)
- 17.820
- +0.040+0.22%
Close Apr 17 15:59 ET
- 18.000
- +0.180+1.01%
Post 20:01 ET
56.30BMarket Cap80.27P/E (TTM)
17.980High17.790Low2.81MVolume17.790Open17.780Prev Close50.18MTurnover0.09%Turnover Ratio84.45P/E (Static)3.16BShares18.89552wk High1.17P/B54.48BFloat Cap12.99052wk Low0.63Dividend TTM3.06BShs Float19.024Historical High3.53%Div Yield TTM1.07%Range %10.810Historical Low17.857Avg Price1Lot Size
Takeda Pharmaceutical (TAK) Key Financial Indicators
TAK Earnings per Share (EPS)
According to the latest financial report of Takeda Pharmaceutical, the latest earnings per share (TTM) for the company is 32.34. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
TAK Free Cash Flow (FCF)
Interested in knowing about Takeda Pharmaceutical's free cash flow? The latest report shows it as 150.88B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
TAK Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Takeda Pharmaceutical shows that the company's current ratio is 1.19, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
TAK Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Takeda Pharmaceutical, the quick ratio is 0.58, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
TAK Return on Equity (ROE)
Want to learn more about the financial health of Takeda Pharmaceutical? The latest ROE figure is 1.40%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
TAK Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Takeda Pharmaceutical, the total asset return on investment (ROA) is 0.69%.
Currency: JPY
Quarterly
Loading...
TAK Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Takeda Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 66.34%.
Currency: JPY
Quarterly
Loading...
TAK Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Takeda Pharmaceutical, the net profit margin is 8.70%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm